Castlelake recently closed on $1.4 billion in new capital commitments, bringing its total managed assets to $3.6 billion.
latest articles
The cable and Internet provider said the grant money will go to non-profit groups in the Twin Cities to increase access to technology and assist digital literacy training in low-income areas.
Bixby Energy Systems founder Robert Walker was convicted on 17 counts of criminal conduct, including witness tampering and defrauding investors, after just a day and a half of jury deliberation.
Dublin-based convenience foods manufacturer Greencore Group recently acquired Shakopee-based Lettieri’s, LLC, to bolster its “food-to-go” business.
The Hastings-based fitness franchise announced Monday that an affiliate of Atlanta-based Roark Capital Group has made an equity investment in the company to “accelerate [its] U.S. and global expansion.”
The Bloomington mall confirmed recently that, after closing on $300 million in financing, it plans to add a 700,000-square-foot expansion.
Minneapolis hopes benchmark requirements will jumpstart energy efficiency updates.
Less than a month after the company’s CEO resigned, Famous Dave’s chose to fire its president and chief operating officer.
Robert Walker’s investment fraud case continues as a 12-person jury met on Monday to deliberate over his 17 criminal counts of fraud, conspiracy, tax evasion, and witness tampering.
City report outlines redevelopment plan for Kmart site.
Now open to all Christians, Thrivent Financial took another step away from its Lutheran exclusivity with a rebranding effort.
But overall market holds steady.
Claiming to have the majority market share of its industry, American Surplus and Manufacturing is opening a new facility in Pine River that it said will bring 20 jobs to the city.
The Minnesotans who made last year’s list also appeared this year, although their rankings and net worth have changed.
The fourth-quarter expansions brought the annual total to 146 in Minnesota, which are expected to create nearly 8,000 jobs in the state.
The company, which develops products to treat urologic conditions, said that it will use the money to seek FDA approval for one of its treatments, to introduce that treatment to the European market, and to conduct cancer research.